Nasdaq

Medtronic Announces FDA Approval Of Simplera CGM; Partners With Abbott To Expand CGM Options

(RTTNews) - Medtronic plc (MDT) announced the U.S. Food and Drug Administration approval for Simplera continuous glucose monitor, or CGM, the company's first disposable, all-in-one CGM that's half the ...
Healio

Fully-implantable CGM receives FDA authorization for integration with insulin pumps

Please provide your email address to receive an email when new articles are posted on . The FDA granted marketing approval to allow the Eversense E3 CGM to be integrated with insulin delivery systems.
Nasdaq

Eversense® CGM System Receives iCGM Designation by the US FDA

The first fully implantable continuous glucose monitors can now be integrated with insulin pumps as part of an automated insulin delivery system As the first fully implantable device in the category, ...
Seeking Alpha

Medtronic advances Abbott CGM partnership with FDA submission of interoperable insulin pump

GALWAY, Ireland, April 24, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has submitted 510(k) applications to the U.S. Food and Drug ...
Business Wire

Eversense 365 Receives FDA Clearance: The World’s First One Year CGM

With a single sensor, the Eversense 365 system provides one year of use, versus 10-14 days with short-term CGM’s for minimal life disruption “The approval of Eversense 365 represents a significant ...